Global CAD For Breast Cancer Screening Market To Accrue USD 122 Million By 2028

June 22, 2022


According to the market assessment report titled ‘Global CAD for Breast Cancer Screening Market 2022-2028’ available with MarketStudyReport, global CAD for breast cancer screening market is slated to register a CAGR of 6.8% over the next six years, accumulating a valuation of USD 122 million by 2028.


Burgeoning incidences of breast cancer among women over the past few years is a primary factor fueling global CAD for breast cancer screening market growth.


Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042769/  


For those unaware, CAD or computer-aided detection is a software that has gained popularity in the arena of radiology as it aids in detecting growth of cancer cells at the primitive stage, thereby facilitating a concrete treatment procedure with improved results.


As per a report by the World Health Organization, approximately 2.3 million women globally were found to be affected by breast cancer in early 2020, out of which nearly 685,000 have reportedly succumbed to the disease.


Apart from the growth drivers and opportunities, the research literature provides critical information regarding the augmentation history and current business landscape in order to make estimations about growth rate and valuation over 2022-2028 for worldwide CAD for breast cancer screening industry. Also, insights into regulatory framework and recent competitive developments are furnished in the report to facilitate a clear understanding of market dynamics among stakeholders thereby enabling them to make well-informed decisions.


Moving on, the document extensively examines the industry through the lens of technology. Based on technology, the industry space is split into ultrasound CAD, MRI CAD, PET/CT CAD, and mammography CAD.


Proceeding further, the report incorporates a comprehensive analysis of the market by region (North America, Europe, Asia Pacific) to further elaborate on avenues with promising profit margins.


Speaking of the competitive landscape, leading players influencing global CAD for breast cancer screening industry trends include Siemens Healthineers AG, Fujifilm Corporation, Konica Minolta Inc., Neusoft Corporation, GE Healthcare, Merge Healthcare Inc., Hitachi Ltd., McKesson Corporation, Qlarity Imaging, iCAD Inc., Hologic Inc., CureMetrix, and IMS Giotto S.p.A.

Chat with us